Ran Reshef (R Reshef)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 40

Top Venues

Blood advances

Bone marrow transplantation

American journal of hematology

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Akahoshi, Nikolaos Spyrou, Matthias Hoepting, Paibel Aguayo-Hiraldo, Francis Ayuk, Chantiya Chanswangphuwana, Hannah K Choe, Matthias Eder, Aaron M Etra, Stephan A Grupp, Elizabeth O Hexner, William Joseph Hogan, Carrie L Kitko, Sabrina Kraus, Monzr M Al Malki, Pietro Merli, Muna Qayed, Ran Reshef, Tal Schechter, Evelyn Ullrich, Ingrid Vasova, Matthias Wölfl, Robert Zeiser, Janna Baez, Rahnuma Beheshti, Gilbert Eng, Sigrun Gleich, Stelios Kasikis, Nikolaos Katsivelos, Steven Kowalyk, George Morales, Rachel Young, Zachariah DeFilipp, James L M Ferrara, John E Levine, Ryotaro Nakamura
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis. Blood advances 8 (8) (2024)
Zachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert Eng, Stelios Kasikis, Rahnuma Beheshti, Janna Baez, Yu Akahoshi, Francis Ayuk, Hannah Choe, Aaron Etra, Stephan A Grupp, Elizabeth O Hexner, William Joseph Hogan, Carrie L Kitko, Muna Qayed, Ran Reshef, Ingrid Vasova, Robert Zeiser, Rachel Young, Ernst Holler, James L M Ferrara, Ryotaro Nakamura, John E Levine, Yi-Bin Chen
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD. Blood advances 8 (13) (2024)
Sarah Nikiforow, Jennifer S Whangbo, Ran Reshef, Donald E Tsai, Nancy J Bunin, Rolla F Abu-Arja, Kris Michael Mahadeo, Wen-Kai Weng, Koen van Besien, David Loeb, Sunita D Nasta, Eneida R Nemecek, Weizhi Zhao, Yan Sun, Faith C Galderisi, Justin Wahlstrom, Aditi Mehta, Laurence Isabelle Gamelin, Rajani Dinavahi, Susan E Prockop
Tabelecleucel for EBV+ PTLD following allogeneic HCT or SOT in a multicenter expanded access protocol. Blood advances (2024)
Zachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert W Eng, Stelios Kasikis, Rahnuma Beheshti, Janna Baez, Yu Akahoshi, Francis Ayuketang Ayuk, Hannah K Choe, Aaron M Etra, Stephan A Grupp, Elizabeth O Hexner, William Joseph Hogan, Carrie L Kitko, Muna Qayed, Ran Reshef, Ingrid Vasova, Robert Zeiser, Rachel Young, Ernst Holler, James L M Ferrara, Ryotaro Nakamura, John E Levine, Yi-Bin Chen
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD. Blood advances (2024)
Yu Akahoshi, Nikolaos Spyrou, Daniela Weber, Paibel Aguayo-Hiraldo, Francis Ayuk, Chantiya Chanswangphuwana, Hannah K Choe, Matthias Eder, Aaron M Etra, Stephan A Grupp, Elizabeth O Hexner, William Joseph Hogan, Carrie L Kitko, Sabrina Kraus, Monzr M Al Malki, Pietro Merli, Muna Qayed, Ran Reshef, Tal Schechter, Evelyn Ullrich, Ingrid Vasova, Matthias Wölfl, Robert Zeiser, Janna Baez, Rahnuma Beheshti, Gilbert Eng, Sigrun Gleich, Nikolaos Katsivelos, Steven Kowalyk, George Morales, Rachel Young, Yi-Bin Chen, Ryotaro Nakamura, John E Levine, James L M Ferrara
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD. Blood 144 (9) (2024)
Yu Akahoshi, Nikolaos Spyrou, Matthias Hoepting, Paibel Aguayo-Hiraldo, Francis Ayuk, Chantiya Chanswangphuwana, Hannah K Choe, Matthias Eder, Aaron M Etra, Stephan A Grupp, Elizabeth O Hexner, William Joseph Hogan, Carrie L Kitko, Sabrina Kraus, Monzr M Al Malki, Pietro Merli, Muna Qayed, Ran Reshef, Tal Schechter, Evelyn Ullrich, Ingrid Vasova, Matthias Wölfl, Robert Zeiser, Janna Baez, Rahnuma Beheshti, Gilbert Eng, Sigrun Gleich, Stelios Kasikis, Nikolaos Katsivelos, Steven Kowalyk, George Morales, Rachel Young, Zachariah DeFilipp, James L M Ferrara, John E Levine, Ryotaro Nakamura
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis. Blood advances 8 (8) (2024)
Yu Akahoshi, Nikolaos Spyrou, Daniela Weber, Paibel Aguayo-Hiraldo, Francis Ayuk, Chantiya Chanswangphuwana, Hannah K Choe, Matthias Eder, Aaron M Etra, Stephan A Grupp, Elizabeth O Hexner, William Joseph Hogan, Carrie L Kitko, Sabrina Kraus, Monzr M Al Malki, Pietro Merli, Muna Qayed, Ran Reshef, Tal Schechter, Evelyn Ullrich, Ingrid Vasova, Matthias Wölfl, Robert Zeiser, Janna Baez, Rahnuma Beheshti, Gilbert Eng, Sigrun Gleich, Nikolaos Katsivelos, Steven Kowalyk, George Morales, Rachel Young, Yi-Bin Chen, Ryotaro Nakamura, John E Levine, James L M Ferrara
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD. Blood 144 (9) (2024)
Yu Akahoshi, Nikolaos Spyrou, Matthias Hoepting, Paibel Aguayo-Hiraldo, Francis Ayuk, Chantiya Chanswangphuwana, Hannah K Choe, Matthias Eder, Aaron M Etra, Stephan A Grupp, Elizabeth O Hexner, William Joseph Hogan, Carrie L Kitko, Sabrina Kraus, Monzr M Al Malki, Pietro Merli, Muna Qayed, Ran Reshef, Tal Schechter, Evelyn Ullrich, Ingrid Vasova, Matthias Wölfl, Robert Zeiser, Janna Baez, Rahnuma Beheshti, Gilbert Eng, Sigrun Gleich, Stelios Kasikis, Nikolaos Katsivelos, Steven Kowalyk, George Morales, Rachel Young, Zachariah DeFilipp, James L M Ferrara, John E Levine, Ryotaro Nakamura
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis. Blood advances 8 (8) (2024)
Zachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert Eng, Stelios Kasikis, Rahnuma Beheshti, Janna Baez, Yu Akahoshi, Francis Ayuk, Hannah Choe, Aaron Etra, Stephan A Grupp, Elizabeth O Hexner, William Joseph Hogan, Carrie L Kitko, Muna Qayed, Ran Reshef, Ingrid Vasova, Robert Zeiser, Rachel Young, Ernst Holler, James L M Ferrara, Ryotaro Nakamura, John E Levine, Yi-Bin Chen
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD. Blood advances 8 (13) (2024)
Zachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert Eng, Stelios Kasikis, Rahnuma Beheshti, Janna Baez, Yu Akahoshi, Francis Ayuk, Hannah Choe, Aaron Etra, Stephan A Grupp, Elizabeth O Hexner, William Joseph Hogan, Carrie L Kitko, Muna Qayed, Ran Reshef, Ingrid Vasova, Robert Zeiser, Rachel Young, Ernst Holler, James L M Ferrara, Ryotaro Nakamura, John E Levine, Yi-Bin Chen
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD. Blood advances 8 (13) (2024)
Yu Akahoshi, Nikolaos Spyrou, Matthias Hoepting, Paibel Aguayo-Hiraldo, Francis Ayuk, Chantiya Chanswangphuwana, Hannah K Choe, Matthias Eder, Aaron M Etra, Stephan A Grupp, Elizabeth O Hexner, William Joseph Hogan, Carrie L Kitko, Sabrina Kraus, Monzr M Al Malki, Pietro Merli, Muna Qayed, Ran Reshef, Tal Schechter, Evelyn Ullrich, Ingrid Vasova, Matthias Wölfl, Robert Zeiser, Janna Baez, Rahnuma Beheshti, Gilbert Eng, Sigrun Gleich, Stelios Kasikis, Nikolaos Katsivelos, Steven Kowalyk, George Morales, Rachel Young, Zachariah DeFilipp, James L M Ferrara, John E Levine, Ryotaro Nakamura
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis. Blood advances 8 (8) (2024)
Yu Akahoshi, Nikolaos Spyrou, Daniela Weber, Paibel Aguayo-Hiraldo, Francis Ayuketang Ayuk, Chantiya Chanswangphuwana, Hannah K Choe, Matthias Eder, Aaron M Etra, Stephan A Grupp, Elizabeth O Hexner, William Joseph Hogan, Carrie L Kitko, Sabrina Kraus, Monzr M Al Malki, Pietro Merli, Muna Qayed, Ran Reshef, Tal Schechter, Evelyn Ullrich, Ingrid Vasova, Matthias Wölfl, Robert Zeiser, Janna Baez, Rahnuma Beheshti, Gilbert W Eng, Sigrun Gleich, Nikolaos Katsivelos, Steven Kowalyk, George Morales, Rachel Young, Yi-Bin Chen, Ryotaro Nakamura, John E Levine, James L M Ferrara
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD. Blood (2024)
Sarah Nikiforow, Jennifer S Whangbo, Ran Reshef, Donald E Tsai, Nancy J Bunin, Rolla F Abu-Arja, Kris Michael Mahadeo, Wen-Kai Weng, Koen van Besien, David Loeb, Sunita Dwivedy Nasta, Eneida R Nemecek, Weizhi Zhao, Yan Sun, Faith Galderisi, Justin Wahlstrom, Aditi Mehta, Laurence Gamelin, Rajani Dinavahi, Susan E Prockop
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol. Blood advances 8 (12) (2024)
Zachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert Eng, Stelios Kasikis, Rahnuma Beheshti, Janna Baez, Yu Akahoshi, Francis Ayuk, Hannah Choe, Aaron Etra, Stephan A Grupp, Elizabeth O Hexner, William Joseph Hogan, Carrie L Kitko, Muna Qayed, Ran Reshef, Ingrid Vasova, Robert Zeiser, Rachel Young, Ernst Holler, James L M Ferrara, Ryotaro Nakamura, John E Levine, Yi-Bin Chen
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD. Blood advances 8 (13) (2024)
Sarah Nikiforow, Jennifer S Whangbo, Ran Reshef, Donald E Tsai, Nancy J Bunin, Rolla F Abu-Arja, Kris Michael Mahadeo, Wen-Kai Weng, Koen van Besien, David Loeb, Sunita Dwivedy Nasta, Eneida R Nemecek, Weizhi Zhao, Yan Sun, Faith Galderisi, Justin Wahlstrom, Aditi Mehta, Laurence Gamelin, Rajani Dinavahi, Susan E Prockop
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol. Blood advances 8 (12) (2024)
Yu Akahoshi, Nikolaos Spyrou, Matthias Hoepting, Paibel Aguayo-Hiraldo, Francis Ayuketang Ayuk, Chantiya Chanswangphuwana, Hannah K Choe, Matthias Eder, Aaron M Etra, Stephan A Grupp, Elizabeth O Hexner, William Joseph Hogan, Carrie L Kitko, Sabrina Kraus, Monzr M Al Malki, Pietro Merli, Muna Qayed, Ran Reshef, Tal Schechter-Finkelstein, Evelyn Ullrich, Ingrid Vasova, Matthias Wölfl, Robert Zeiser, Janna Baez, Rahnuma Beheshti, Gilbert W Eng, Sigrun Gleich, Stelios Kasikis, Nikolaos Katsivelos, Steven Kowalyk, George Morales, Rachel Young, Zachariah DeFilipp, James L M Ferrara, John E Levine, Ryotaro Nakamura
Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis. Blood advances (2024)
Sarah Nikiforow, Jennifer S Whangbo, Ran Reshef, Donald E Tsai, Nancy J Bunin, Rolla F Abu-Arja, Kris Michael Mahadeo, Wen-Kai Weng, Koen van Besien, David Loeb, Sunita Dwivedy Nasta, Eneida R Nemecek, Weizhi Zhao, Yan Sun, Faith Galderisi, Justin Wahlstrom, Aditi Mehta, Laurence Gamelin, Rajani Dinavahi, Susan E Prockop
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol. Blood advances 8 (12) (2024)
Philip L McCarthy, Kristopher M Attwood, Xiaojun Liu, George L Chen, Hans Minderman, Amin M Alousi, Asad Bashey, Robert Lowsky, David Bernard Miklos, John Hansen, Peter Westervelt, Gregory Yanik, Edmund K Waller, Alan Howard, Bruce R Blazar, Paul K Wallace, Ran Reshef, Mary M Horowitz, Richard T Maziarz, John E Levine, Hemn Mohammadpour
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone marrow transplantation 59 (3) (2023)
Philip L McCarthy, Kristopher M Attwood, Xiaojun Liu, George L Chen, Hans Minderman, Amin M Alousi, Asad Bashey, Robert Lowsky, David Bernard Miklos, John Hansen, Peter Westervelt, Gregory Yanik, Edmund K Waller, Alan Howard, Bruce R Blazar, Paul K Wallace, Ran Reshef, Mary M Horowitz, Richard T Maziarz, John E Levine, Hemn Mohammadpour
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone marrow transplantation (2023)
Michael D Jain, David Bernard Miklos, Caron A Jacobson, John M Timmerman, Jennifer Sun, Jenny Nater, Xiang Fang, Ankit Patel, Madison Davis, Darren Heeke, Tan Trinh, Mike Mattie, Frank Neumann, Jenny J Kim, Christina To, Simone Filosto, Ran Reshef
Axicabtagene Ciloleucel in Combination With the 4-1BB Agonist Utomilumab in Patients With Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results From ZUMA-11. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yu Akahoshi, Nikolaos Spyrou, William Joseph Hogan, Francis Ayuketang Ayuk, Zachariah DeFilipp, Daniela Weber, Hannah K Choe, Elizabeth O Hexner, Wolf Rösler, Aaron M Etra, Karamjeet Singh Sandhu, Gregory A Yanik, Chantiya Chanswangphuwana, Carrie L Kitko, Ran Reshef, Sabrina Kraus, Matthias Wölfl, Matthias Eder, Hannah Bertrand, Muna Qayed, Pietro Merli, Stephan A Grupp, Paibel Aguayo-Hiraldo, Tal Schechter, Evelyn Ullrich, Janna Baez, Rahnuma Beheshti, Sigrun Gleich, Steven Kowalyk, George Morales, Rachel Young, Deukwoo Kwon, Ryotaro Nakamura, John E Levine, James L M Ferrara, Yi-Bin Chen
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD. Blood advances (2023)
Philip L McCarthy, Kristopher M Attwood, Xiaojun Liu, George L Chen, Hans Minderman, Amin M Alousi, Asad Bashey, Robert Lowsky, David Bernard Miklos, John Hansen, Peter Westervelt, Gregory Yanik, Edmund K Waller, Alan Howard, Bruce R Blazar, Paul K Wallace, Ran Reshef, Mary M Horowitz, Richard T Maziarz, John E Levine, Hemn Mohammadpour
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone marrow transplantation 59 (3) (2023)
Philip L McCarthy, Kristopher M Attwood, Xiaojun Liu, George L Chen, Hans Minderman, Amin M Alousi, Asad Bashey, Robert Lowsky, David Bernard Miklos, John Hansen, Peter Westervelt, Gregory Yanik, Edmund K Waller, Alan Howard, Bruce R Blazar, Paul K Wallace, Ran Reshef, Mary M Horowitz, Richard T Maziarz, John E Levine, Hemn Mohammadpour
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone marrow transplantation 59 (3) (2023)
Rajshekhar Chakraborty, Divaya Bhutani, Markus Mapara, Ran Reshef, Mathew S Maurer, Jai Radhakrishnan, Suzanne Lentzsch
Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study. American journal of hematology 99 (3) (2023)
Rajshekhar Chakraborty, Divaya Bhutani, Markus Mapara, Ran Reshef, Mathew S Maurer, Jai Radhakrishnan, Suzanne Lentzsch
Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study. American journal of hematology 99 (3) (2023)
Rajshekhar Chakraborty, Divaya Bhutani, Markus Mapara, Ran Reshef, Mathew S Maurer, Jai Radhakrishnan, Suzanne Lentzsch
Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study. American journal of hematology (2023)
Philip L McCarthy, Kristopher M Attwood, Xiaojun Liu, George L Chen, Hans Minderman, Amin M Alousi, Asad Bashey, Robert Lowsky, David Bernard Miklos, John Hansen, Peter Westervelt, Gregory Yanik, Edmund K Waller, Alan Howard, Bruce R Blazar, Paul K Wallace, Ran Reshef, Mary M Horowitz, Richard T Maziarz, John E Levine, Hemn Mohammadpour
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone marrow transplantation 59 (3) (2023)
Rajshekhar Chakraborty, Divaya Bhutani, Markus Mapara, Ran Reshef, Mathew S Maurer, Jai Radhakrishnan, Suzanne Lentzsch
Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study. American journal of hematology 99 (3) (2023)
Philip L McCarthy, Kristopher M Attwood, Xiaojun Liu, George L Chen, Hans Minderman, Amin M Alousi, Asad Bashey, Robert Lowsky, David Bernard Miklos, John Hansen, Peter Westervelt, Gregory Yanik, Edmund K Waller, Alan Howard, Bruce R Blazar, Paul K Wallace, Ran Reshef, Mary M Horowitz, Richard T Maziarz, John E Levine, Hemn Mohammadpour
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone marrow transplantation 59 (3) (2023)
Philip L McCarthy, Kristopher M Attwood, Xiaojun Liu, George L Chen, Hans Minderman, Amin M Alousi, Asad Bashey, Robert Lowsky, David Bernard Miklos, John Hansen, Peter Westervelt, Gregory Yanik, Edmund K Waller, Alan Howard, Bruce R Blazar, Paul K Wallace, Ran Reshef, Mary M Horowitz, Richard T Maziarz, John E Levine, Hemn Mohammadpour
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone marrow transplantation 59 (3) (2023)
Javier Bolaños-Meade, Mehdi Hamadani, Juan Wu, Monzr M Al Malki, Michael J Martens, Lyndsey Runaas, Hany Elmariah, Andrew R Rezvani, Mahasweta Gooptu, Karilyn T Larkin, Brian C Shaffer, Najla El Jurdi, Alison W Loren, Melhem Solh, Aric C Hall, Amin M Alousi, Omer H Jamy, Miguel-Angel Perales, Janny M Yao, Kristy Applegate, Ami Siddharth Bhatt, Leslie S Kean, Yvonne A Efebera, Ran Reshef, William Clark, Nancy L DiFronzo, Eric S Leifer, Mary M Horowitz, Richard J Jones, Shernan G Holtan, null null
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. The New England journal of medicine 388 (25) (2023)
Philip L McCarthy, Kristopher M Attwood, Xiaojun Liu, George L Chen, Hans Minderman, Amin M Alousi, Asad Bashey, Robert Lowsky, David Bernard Miklos, John Hansen, Peter Westervelt, Gregory Yanik, Edmund K Waller, Alan Howard, Bruce R Blazar, Paul K Wallace, Ran Reshef, Mary M Horowitz, Richard T Maziarz, John E Levine, Hemn Mohammadpour
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone marrow transplantation (2023)
Philip L McCarthy, Kristopher M Attwood, Xiaojun Liu, George L Chen, Hans Minderman, Amin M Alousi, Asad Bashey, Robert Lowsky, David Bernard Miklos, John Hansen, Peter Westervelt, Gregory Yanik, Edmund K Waller, Alan Howard, Bruce R Blazar, Paul K Wallace, Ran Reshef, Mary M Horowitz, Richard T Maziarz, John E Levine, Hemn Mohammadpour
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone marrow transplantation 59 (3) (2023)
Zoila A Lopez-Bujanda, Aleksandar Z Obradovic, Thomas R Nirschl, Laura Crowley, Rodney Macedo, Alexandros Papachristodoulou, Timothy O'Donnell, Uri Laserson, Jelani C Zarif, Ran Reshef, Tiezheng Yuan, Mithil K Soni, Emmanuel S Antonarakis, Michael C Haffner, H Benjamin Larman, Michael M Shen, Pawel Muranski, Charles G Drake
TGM4: an immunogenic prostate-restricted antigen. Journal for immunotherapy of cancer 9 (6) (2022)
Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei-Jie Zhang, Khalid Bo-Subait, Jonathan Sanchez, Hai-Lin Wang, Mahmoud Aljurf, Amer Assal, Vera Ulrike Bacher, Sherif M Badawy, Nelli Bejanyan, Vijaya Raj Bhatt, Christopher N Bredeson, Michael Byrne, Paul Castillo, Jan Cerny, Saurabh Chhabra, Stefan Octavian Ciurea, Zachariah DeFilipp, Nosha Farhadfar, Shahinaz M Gadalla, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael Richard Grunwald, Shahrukh K. Hashmi, Gerhard Carl Hildebrandt, Christopher G Kanakry, Ankit Kansagra, Farhad Khimani, Maxwell M Krem, Hillard M Lazarus, Hongtao Liu, Rodrigo Martino Bofarull, Fotios V Michelis, Sunita Nathan, Taiga Nishihori, Richard F Olsson, Ran Reshef, David A Rizzieri, Jacob M Rowe, Bipin P Savani, Sachiko Seo, Akshay Sharma, Melhem Solh, Celalettin Ustun, Leo F Verdonck, Christopher S Hourigan, Brenda M Sandmaier, Mark R Litzow, Partow Kebriaei, Daniel J Weisdorf, Yanming Zhang, Martin S Tallman, Wael Saber
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood advances (2021)
Mahasweta Gooptu, Rizwan Romee, Andrew St Martin, Mukta Arora, Monzr M Al Malki, Joseph H Antin, Christopher N Bredeson, Claudio G Brunstein, Saurabh Chhabra, Ephraim J Fuchs, Nilanjan Ghosh, Michael R Grunwald, Christopher G Kanakry, Natasha Kekre, Joseph P McGuirk, Ian K McNiece, Rohtesh S Mehta, Marco B Mielcarek, Filippo Milano, Dipenkumar Modi, Ran Reshef, Scott R Solomon, Mark A Schroeder, Edmund K Waller, Yoshiro Inamoto, Robert J Soiffer, Mary Eapen
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis. Blood 138 (3) (2021)
Ran Reshef, Wael Saber, Javier Bolaños-Meade, George Chen, Yi-Bin Chen, Vincent T Ho, Doris M Ponce, Ryotaro Nakamura, Michael J Martens, John A Hansen, John E Levine
Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (17) (2021)
Neema P Mayor, Tao Wang, Stephanie J Lee, Michelle Kuxhausen, Cynthia Vierra-Green, Dominic J Barker, Jeffrey Auletta, Vijaya Raj Bhatt, Shahinaz M Gadalla, Loren Gragert, Yoshihiro Inamoto, Gerald P Morris, Sophie Paczesny, Ran Reshef, Olle Ringdén, Bronwen E Shaw, Peter J Shaw, Stephen R Spellman, Steven G E Marsh
Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (21) (2021)
Christian A Gordillo, Sapna Parmar, Miranda Blanco, Elsa M Delille, Amer Assal, Markus Mapara, Ran Reshef
Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies. Annals of hematology 100 (7) (2021)
Shan He, Yongnian Liu, Lijun Meng, Hongxing Sun, Ying Wang, Yun Ji, Janaki Purushe, Pan Chen, Changhong Li, Jozef Madzo, Jean-Pierre Issa, Jonathan Soboloff, Ran Reshef, Bethany B Moore, Luca Gattinoni, Yi Zhang
Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity. Nature communications 8 (1) (2017)
A Ganetsky, A Shah, T A Miano, W-T Hwang, J He, A W Loren, E O Hexner, N V Frey, D L Porter, Ran Reshef
Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation. Bone marrow transplantation 51 (4) (2015)
Lijun Meng, Zhenjiang Bai, Shan He, Kazuhiro Mochizuki, Yongnian Liu, Janaki Purushe, Hongxing Sun, Jian Wang, Hideo Yagita, Shin Mineishi, Henry Fung, Gregory A Yanik, Roberto Caricchio, Xiaoxuan Fan, Lisa M Crisalli, Elizabeth O Hexner, Ran Reshef, Yanyun Zhang, Yi Zhang
The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation. Journal of immunology (Baltimore, Md. : 1950) 196 (3) (2015)

Ran Reshef.css-eqlu8i{font-size:small;padding-left:4px;} (R Reshef)

Publication Activity (10 Years)

Top Topics

Top Venues

Ran Reshef (R Reshef)